Fig. 9From: Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysisForest plot representing the odds ratio of adverse events experienced by patients from the C/PI and II groups in included studiesBack to article page